VEINAMINE 8%
LOE Approachingamino acids; magnesium chloride; potassium acetate; potassium chloride; sodium acetate
NDAINJECTIONINJECTABLE
Approved
Jan 1978
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 3h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VEINAMINE 8% is a parenteral nutrition formulation containing amino acids, electrolytes (magnesium chloride, potassium acetate, potassium chloride, sodium acetate) administered intravenously. It provides essential amino acids and electrolyte support for patients unable to obtain adequate nutrition through oral intake. This product is a nutritional supplement rather than a disease-modifying therapy.
LOE Approaching
This mature nutritional product with approaching loss of exclusivity faces moderate competitive pressure (30%) and likely operates with a stable, lean commercial team focused on hospital and specialty channels.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on VEINAMINE 8% offers limited growth opportunity given its mature lifecycle and approaching loss of exclusivity, with career focus shifted toward operational efficiency, hospital relationships, and cost management rather than innovation. This role suits professionals seeking stable, relationship-based work in specialty pharmaceuticals or those transitioning to generic product management.
Hospital Account Manager
Worked on VEINAMINE 8% at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.